Evidence map›Paper›PMID 42038526›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026

Association Between Thyroid Hormone Sensitivity Indicators and Controlled Attenuation Parameter (CAP) Values in Euthyroid Adults with Overweight/Obesity.

Yifang Zhang, Cuiping Bao, Lingling Liu, Renjiao Liu, Xincheng Wang, Xiaoxuan Guo, Chunjun Li

Abstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yifang Zhang *School of Medicine, Nankai University, Tianjin, People's Republic of China.ORCID 0000-0003-4857-8146
Cuiping Bao *Department of Radiology, Tianjin Union Medical Center, the First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
Lingling LiuGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
Renjiao LiuGraduate School, Tianjin Medical University, Tianjin, People's Republic of China.
Xincheng WangDepartment of Health Management Center, Tianjin Union Medical Center, the First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
Xiaoxuan GuoDepartment of Health Management Center, Tianjin Union Medical Center, the First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.ORCID 0009-0004-3324-077X
Chunjun LiSchool of Medicine, Nankai University, Tianjin, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obesity is an established contributor to hepatic steatosis. Despite weight control efforts, the incidence of steatosis and its associated hepatic complications continues to increase, highlighting the critical need to identify obesity-related pathogenic mechanisms for developing effective therapeutic strategies. Aim: This study aims to explore the association between thyroid hormone sensitivity indicators and hepatic steatosis assessed by controlled attenuation parameter (CAP) values in euthyroid individuals with overweight/obesity. Methods: Sensitivity to THs, was evaluated using TFQI Results: Compared to the non-severe hepatic steatosis group, the severe hepatic steatosis group exhibited significantly higher levels of TFQI Conclusion: The correlation between TH sensitivity and hepatic steatosis was significantly stronger in TFQI

Indexed as

FT3/FT4 ratiohepatic steatosisobesityTFQIthyroid hormone sensitivity

Identifiers

PMID42038526
PMCPMC13102751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.